For patients with skin of color and atopic dermatitis (AD), lebrikizumab is efficacious and safe, according to a study ...

特应性皮炎（Atopic Dermatitis, AD）是一种令人困扰的慢性皮肤病，很多人可能会问：它究竟是什么病？为何有些人在公共场合也无法控制瘙痒？面对中重度特应性皮炎的患者，他们的生活又是怎样的？ 特应性皮炎的病因复杂，主要与皮肤屏障功能受损、免疫系统失调以及神经系统相互作用有关。根据复旦大学附属华山医院的顾超颖教授，特应性皮炎是一种复发性炎症性疾病，全球有超过2.3亿人受到其影响。在中国， ...

A Japanese research team has found that cells often labeled “villains” for their roles in atopic dermatitis and asthma can ...

Corvus Pharmaceuticals Inc. (($CRVS)) has held its Q2 earnings call. Read on for the main highlights of the call. Corvus Pharmaceuticals’ recent ...

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today reported financial results for the ...

COSMAX announced on the 13th that its MD cream (adhesive transparent wound dressing) featuring the skin microbiome-based ...